首页> 外文期刊>Chest >Catheter-Directed Embolectomy, Fragmentation, and Thrombolysis for the Treatment of Massive Pulmonary Embolism After Failure of Systemic Thrombolysis*
【24h】

Catheter-Directed Embolectomy, Fragmentation, and Thrombolysis for the Treatment of Massive Pulmonary Embolism After Failure of Systemic Thrombolysis*

机译:全身性溶栓失败后行导管定向栓塞切除术,破碎和溶栓治疗大规模肺栓塞*

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The standard medical management for patients in extremis from massive pulmonary embolism (PE) is systemic thrombolysis, but the utility of this treatment relative to catheter-directed intervention (CDI) is unknown. We evaluated the effectiveness of CDI as part of a treatment algorithm for life-threatening PE. nnMethods: A retrospective review was performed on 70 consecutive patients with suspected acute PE over a 10-year period (from 1997 to 2006) who had been referred for pulmonary angiography and/or intervention. The criteria for study inclusion were patients who received CDI due to angiographically confirmed massive PE and hemodynamic shock (shock index, 0.9). CDI involved suction embolectomy and fragmentation with or without catheter thrombolysis. nnResults: Twelve patients were treated with CDI. There were seven men and five women (mean age, 56 years; age range, 21 to 80 years). Seven patients (58%) were referred for CDI after failing systemic infusion with 100 mg of tissue plasminogen activator, and five patients (42%) had contraindications to systemic thrombolysis. Catheter-directed fragmentation and embolectomy were performed in all patients (100%). Additionally, catheter-guided thrombolysis was performed in eight patients (67%). Technical success was achieved in 12 of 12 cases (100%). There were no major procedural complications (0%). Significant hemodynamic improvement (shock index, < 0.9) was observed in 10 of 12 cases (83%). The remaining two patients (17%) died secondary to cardiac arrest within 24 h. Ten of 12 patients (83%) survived and remained stable until hospital discharge (mean duration, 20 days; range, 3 to 51 days). nnConclusion: In the setting of hemodynamic shock from massive PE, CDI is potentially a life-saving treatment for patients who have not responded to or cannot tolerate systemic thrombolysis.
机译:目的:患有大面积肺栓塞(PE)的极端患者的标准医疗管理是全身溶栓,但相对于导管直接干预(CDI)而言,这种治疗的效用尚不清楚。我们评估了CDI作为威胁生命的PE的治疗算法的一部分的有效性。 nn方法:回顾性分析了10年来(1997年至2006年)连续70例疑似急性PE的患者,这些患者被转诊接受肺血管造影和/或介入治疗。纳入研究的标准是因血管造影证实的大量PE和血流动力学休克而接受CDI的患者(休克指数,0.9)。 CDI涉及抽吸栓子切除术,并伴或不伴导管溶栓而破裂。结果:12例患者接受了CDI治疗。男7例,女5例(平均年龄56岁;年龄范围21至80岁)。全身输注100 mg组织纤溶酶原激活剂失败后,有7名患者(58%)被转诊为CDI,五名患者(42%)出现全身性溶栓的禁忌症。所有患者(100%)均进行了导管定向破碎术和栓子切除术。另外,在八名患者(67%)中进行了导管引导的溶栓治疗。 12例中有12例获得了技术成功(100%)。没有重大的手术并发症(0%)。 12例中有10例(83%)观察到明显的血液动力学改善(休克指数,<0.9)。其余两名患者(17%)在24小时内死于心脏骤停。 12例患者中有10例(83%)存活并保持稳定,直到出院为止(平均持续时间20天;范围3到51天)。结论:在大块PE引起的血流动力学休克的情况下,对于那些对全身溶栓治疗无反应或不能耐受的患者,CDI可能是挽救生命的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号